MERTK and metabolic dysfunction-associated steatohepatitis: In the progression from NAFLD to nonalcoholic steatohepatitis (NASH), these polymorphisms, which are associated with reduced Mer expression, are linked to reduced risk for liver fibrosis (Cavalli et al, 2017).